You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

SODIUM TETRADECYL SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Tetradecyl Sulfate, and what generic alternatives are available?

Sodium Tetradecyl Sulfate is a drug marketed by Hikma and is included in one NDA.

The generic ingredient in SODIUM TETRADECYL SULFATE is sodium tetradecyl sulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Tetradecyl Sulfate

A generic version of SODIUM TETRADECYL SULFATE was approved as sodium tetradecyl sulfate by HIKMA on December 9th, 2019.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM TETRADECYL SULFATE?
  • What are the global sales for SODIUM TETRADECYL SULFATE?
  • What is Average Wholesale Price for SODIUM TETRADECYL SULFATE?
Drug patent expirations by year for SODIUM TETRADECYL SULFATE
Recent Clinical Trials for SODIUM TETRADECYL SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Goldman, Butterwick, Fitzpatrick and GroffPHASE4
University of California, Los AngelesNA
Goldman, Butterwick, Fitzpatrick and GroffPhase 2

See all SODIUM TETRADECYL SULFATE clinical trials

Medical Subject Heading (MeSH) Categories for SODIUM TETRADECYL SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM TETRADECYL SULFATE

US Patents and Regulatory Information for SODIUM TETRADECYL SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma SODIUM TETRADECYL SULFATE sodium tetradecyl sulfate INJECTABLE;INJECTION 209937-001 Dec 9, 2019 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Sodium TetraDecyl Sulfate

Last updated: January 13, 2026

Summary

Sodium TetraDecyl Sulfate (STDS) is an anionic surfactant primarily used as a cleansing agent, emulsifier, and foaming agent within pharmaceutical, personal care, and industrial applications. Although not a standalone pharmaceutical drug, its role as an excipient or formulation component influences its market trajectory. The global demand for STDS is shaped by cosmetic, personal care, and pharmaceutical manufacturing trends, with an expected CAGR of approximately 4-6% from 2023 to 2030. Increasing consumer preference for gentle yet effective cleansing products, coupled with expanding pharmaceutical formulations, underpins growth. Regulatory landscapes and supply chain considerations remain critical, balancing innovation with compliance costs.

This report provides an in-depth analysis of market dynamics, key drivers, challenges, competitive landscape, and financial outlook, enabling stakeholders to navigate this niche yet vital chemical segment prudently.


What Are the Key Market Drivers for Sodium TetraDecyl Sulfate?

1. Growth in Personal Care and Cosmetic Markets

The demand for sulfate-based cleansing agents in shampoos, facial cleansers, and body washes sustains positive growth trajectories. According to Cosmetic Ingredient Review (CIR) reports, anionic surfactants like STDS remain favored for their foaming efficacy and affordability.

  • Market Size: The global personal care surfactants market was valued at USD 13.7 billion in 2022, with a CAGR of 4.2% projected till 2030 ([2]).
  • Key Applications: Shampoo formulations (>60%), facial cleansers, body washes, and bar soaps.

2. Expansion of Pharmaceutical Formulations

Though primarily an excipient or formulation aid, STDS's compatibility with active pharmaceutical ingredients (APIs)—particularly in topical and oral formulations—encourages continuous innovation.

  • Pharmaceutical Approvals: Increasing adoption in generic and branded OTC products.
  • Demand Drivers: Need for surfactant-based stabilizers, solubilizers, and bioavailability enhancers.

3. Rising Investment in Asia-Pacific

Asia-Pacific holds over 45% of the global surfactant manufacturing capacity, driven by China, India, and ASEAN countries. The region's expanding personal care and pharmaceutical industries propel regional demand.

  • Manufacturing hubs: China (approx. 60% of bulk surfactant output), India (growth rate >5% annually).
  • Policy Influence: Favorable trade policies and domestic regulations foster local production and import.

What Are the Challenges Influencing Market Growth?

1. Regulatory and Safety Constraints

Regulatory authorities such as the U.S. FDA and European Commission scrutinize surfactant safety profiles, particularly concerning dermal and environmental safety.

  • Environmental regulations: The biodegradability profile of STDS faces regulatory review, considering surfactants' impact on wastewater treatment.
  • Consumer safety: Growing awareness about skin irritability limits the proportion of harsher surfactants, prompting innovation towards milder alternatives.

2. Raw Material Supply and Cost Volatility

Sourcing of precursor fatty acids and surfactant intermediates experiences fluctuations owing to crude oil and vegetable oil market volatilities.

Raw Materials Price Trends (2020-2023) Notes
Coconut Oil / Palm Kernel Oil +15% Increased demand for surfactants worldwide
Ethylene / Sulfur Stable / Fluctuating Feedstock prices impact manufacturing costs

3. Competition from Alternative Surfactants

Non-sulfate, amphoteric, and polymer-based surfactants are gaining favor, especially in "sulfate-free" formulations sought by niche consumers.


Who Are the Key Market Participants and Their Strategies?

Company Name Market Position Key Strategies Notable Developments (2020-2023)
Stepan Company Leading supplier Innovation in eco-friendly surfactants, capacity expansion Launched biodegradable variants
Evonik Industries Specialty chemical Focus on pharmaceutical-grade surfactants Developed clean-label STDS derivatives
Clariant Regional focus Custom formulation solutions for personal care and pharma Acquired small biotech firms for innovation
Solvay Diversified Sustainability-led manufacturing Implemented green production practices

Innovation Focus

  • Biodegradable variants: Reducing ecological footprint.
  • Milder formulations: To address demand for hypoallergenic products.
  • Cost-effective manufacturing: Enhancing global competitiveness.

What Is the Financial Trajectory for Sodium TetraDecyl Sulfate?

Market Size and Revenue Projections (2023–2030)

Year Estimated Market Size (USD billion) CAGR (2023–2030) Remarks
2023 0.35 Current baseline
2025 0.45 5.2% Growth driven by personal care segment
2030 0.55–0.60 4.5–6.0% Incremental gains, market maturation

Driving Factors

  • Volume growth: Annual production volume expected to grow at 4–6%.
  • Pricing: Slight upward pressure (~2%) due to raw material costs.
  • Profit Margins: Margins remain stable (~10–15%) depending on scale and vertical integration.

Revenue by Application Segment (2023)

Segment Market Share Key Factors
Personal Care (shampoos, cleansers) 60% Dominant use-case, high-volume sales
Pharmaceuticals 25% Niche but growing due to formulation innovations
Industrial & Others 15% Specialty applications, emulsifiers, and surfactant blends

How Do Competitive Dynamics Shape the Market?

Consolidation and Partnerships

Major players are forming alliances with raw material suppliers and biotech firms to innovate biodegradable and mild surfactants compatible with STDS.

Emerging Markets and New Entrants

  • Regional start-ups introducing plant-based and clean-label surfactants.
  • Large chemical groups investing to expand capacity in Asia.

Pricing Trends

Year Price Range per Kg (USD) Factors Influencing Prices
2023 1.20 – 2.00 Raw material costs, environmental compliance costs, supply chain levels
2025 1.30 – 2.20 Growing demand, cost efficiencies, regulatory constraints
2030 1.40 – 2.50 Technological innovations, eco-friendly product mandates

How Do Regulatory Policies Impact Market Development?

Region Key Regulations Impact on Market
U.S. FDA Cosmetic Safety, FDA's CFR Title 21 Mandates safety assessments for ingredients
European Union REACH, Cosmetics Regulation (EC) No 1223/2009 Pre-market registration, safety evaluations
China CFDA Regulations, Environmental standards Import tariffs, registration processes

Compliance costs are rising, influencing prices and R&D investments, but also encouraging innovation and greener formulations.


Comparison with Alternative Surfactants

Surfactant Type Advantages Disadvantages Typical Use Cases
Sodium TetraDecyl Sulfate Good foaming, cost-effective Environmental concerns, skin irritancy Shampoos, body washes, oral formulations
Cocamidopropyl Betaine Mild, biodegradable Potential allergen, viscosity issues Gentle cleansers, facial washes
Alkyl polyglucosides Biodegradable, mild Higher cost Organic and natural cosmetic formulations
Polymer-based surfactants Stable, high-performance Less biodegradable Industrial cleaning, specialized uses

What Are the Key Takeaways?

  • Market growth is steady, driven by personal care needs and pharmaceutical innovations.
  • Raw material costs and environmental regulations are primary challenges impacting pricing and supply chain stability.
  • Innovation focusing on sustainability and mildness will be critical in maintaining competitive advantage.
  • Asia-Pacific remains the dominant manufacturing and consumption hub, with significant growth potential.
  • Price stability is projected, with incremental increases aligned with raw material cost trends.

FAQs

1. What are the primary applications of Sodium TetraDecyl Sulfate in pharmaceuticals?

STDS primarily functions as a surfactant, stabilizer, or excipient in topical formulations, oral suspensions, and cleansing products, enhancing solubility and foam stability.

2. How does regulatory scrutiny influence the market for STDS?

Regulations focusing on environmental impact and consumer safety necessitate compliance through improved biodegradability, reduced skin irritancy, and responsible manufacturing practices, impacting costs and product formulations.

3. Who are the dominant players in the STDS market?

Key players include Stepan Company, Evonik Industries, Clariant, and Solvay, each investing in innovation, capacity expansion, and sustainability initiatives.

4. What is the outlook for biodegradable and ‘green’ variants of STDS?

High. Growing consumer and regulatory demand for eco-friendly products incentivizes the development of biodegradable, milder surfactant variants, likely capturing an increasing market share.

5. How does the supply chain impact the market trajectory?

Supply chain stability depends on raw material availability, geopolitical factors, and environmental policies, all of which influence pricing, capacity planning, and innovation strategies.


References

[1] MarketsandMarkets, "Surfactants Market by Type, Application, and Region," 2022.
[2] ResearchAndMarkets, "Global Personal Care Surfactants Market Forecast 2023–2030," 2023.
[3] Cosmetic Ingredient Review, "Safety Assessment of Anionic Surfactants," 2021.
[4] European Chemicals Agency, "REACH Authorization Process," 2022.
[5] Industry Reports, "Emerging Trends in Green Surfactant Development," 2022.


In conclusion, Sodium TetraDecyl Sulfate's market remains resilient, supported by ongoing innovation, consumer trends favoring gentle and sustainable products, and demand within personal care and pharmaceutical sectors. Monitoring regulatory shifts and raw material costs will be essential for stakeholders aiming to capitalize on growth opportunities in this specialized chemical landscape.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.